Sonic Incytes is proudly presenting at the EASL Digital International Liver CongressTM, August 27-29, 2020. Visit our booth and read our Poster #FRI050 for a sneak preview of our upcoming product release: VelacurTM, a breakthrough, point of care ultrasound solution for assessing and managing chronic liver disease—an emerging global health epidemic, affecting one in four persons worldwide.
We recognize that healthcare practitioners need a better tool to routinely assess and manage those with identified risk factors for liver disease. VelacurTM is the first handheld 3D liver health assessment tool that is fast, accurate and portable. It provides a clear picture of the liver in real time, so you can be confident in your diagnosis, treatment and care.
Interested to find out more? Contact us at info@www.sonicincytes.com.
